Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.42NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.62NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.23NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.3.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JV.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XCYNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HK.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-2770.32China
JN.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EK.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HV.1.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HV.1.6.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EF.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BU.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.38NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CJ.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.6.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.7.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.3.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FA.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EE.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.72NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBJ.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CK.2.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.86 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.7 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.12 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.7.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.390NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
N.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.319NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BG.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JF.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.572NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.397NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.3 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.523NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.116 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.38 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.595.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.340NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.437NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used